1. The War Is on: The Immune System against Glioblastoma—How Can NK Cells Drive This Battle?
   Lucas Henrique Rodrigues da Silva et al, 2022, Biomedicines CrossRef
2. Interleukin-12 Delivery Strategies and Advances in Tumor Immunotherapy
   Chunyan Dong et al, 2024, Current Issues in Molecular Biology CrossRef
3. Novel Delivery Strategies for Glioblastoma
   Jiangbing Zhou et al, 2012, The Cancer Journal CrossRef
4. Natural killer cells in the treatment of glioblastoma: Diverse antitumor functions and potential clinical applications
   Barbara Breznik et al, 2023, NK Cells in Cancer Immunotherapy: Successes and Challenges CrossRef
5. Long-term expression of rAAV2-hIL15 enhances immunoglobulin production and lymphokine-activated killer cell-mediated human glioblastoma cell death
   GIOU-TENG YIANG et al, 2013, Molecular and Clinical Oncology CrossRef
6. The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology
   Massimo S. Fiandaca et al, 2011, Toxins CrossRef
7. Gene Therapy Approaches Against Cancer Using in Vivo and ex Vivo Gene Transfer of Interleukin-12
   Ruben Hernandez-Alcoceba et al, 2016, Immunotherapy CrossRef
8. Designing cytochrome P450 enzymes for use in cancer gene therapy
   Saskya E. Carrera-Pacheco et al, 2024, Frontiers in Bioengineering and Biotechnology CrossRef
9. TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways
   Qiang-bo Zhang et al, 2024, Scientific Reports CrossRef